Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients
Stopped Lack of eligible patients due to lower number of Covid-19 cases in all involved sites.
Conditions
Interventions
- DRUG: BIO101
- DRUG: Placebo
Sponsor
Biophytis